A microengineered pathophysiological model of early-stage breast cancer
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
We report a microengineered cell culture platform that reconstitutes the 3D architecture and microenvironment of early-stage breast cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This model system enabled the establishment of physiologically relevant tissue architectures, the location of micro-environmental cues, and a direct observation of cell responses.”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [34]
In the citing paper
“In recent years, techniques which can overcome the abnormal vasculature in the tumor, such as nanoparticle drug delivery and drugs normalizing vascular network, were shown to be able to greatly improve anti-cancer treatment [108-113].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [109]
Citations
Cites
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
A tense situation: forcing tumour progression
Butcher, D. T., Alliston, T., & Weaver, V. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2544 · Cited by 1,940
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
Self-citationModeling tissue-specific signaling and organ function in three dimensions
Schmeichel, K. L., & Bissell, M. J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00503 · Cited by 585
Regulation of In Situ to Invasive Breast Carcinoma Transition
Hu, M., Yao, J., Carroll, D. K., Weremowicz, S., Chen, H., Carrasco, D., Richardson, A., Violette, S., Nikolskaya, T., Nikolsky, Y., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.007 · Cited by 502
Cytotoxic studies of paclitaxel (Taxol®) in human tumour cell lines
Liebmann, J., Cook, J., Lipschultz, C., Teague, D., Fisher, J., & Mitchell, J. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.488 · Cited by 428
The microenvironment in breast cancer progression: biology and implications for treatment
Place, A. E., Jin Huh, S., & Polyak, K. (2011) · Breast Cancer Research · doi:10.1186/bcr2912 · Cited by 413
Lyons, T. R., O'Brien, J., Borges, V. F., Conklin, M. W., Keely, P. J., Eliceiri, K. W., Marusyk, A., Tan, A.-C., & Schedin, P. (2011) · Nature Medicine · doi:10.1038/nm.2416 · Cited by 380
Cited by
Items 201–222 of 222
Microfluidics for nanopharmaceutical and medical applications
Adams, F., Zimmermann, C. M., Luciani, P., & Merkel, O. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822482-3.00010-5 · Cited by 2
Microengineered Breast Cancer Models: Shaping the Future of Personalized Oncology
Popoiu, T.-A., Cîmpean, A. M., Bojin, F. M., Cerbu, S., Gug, M.-C., Pirvu, C.-A., Pantea, Ș., & Neagu, A. (2025) · Cancers · doi:10.3390/cancers17193160 · Cited by 1
“When perfused with paclitaxel, the system showed only a moderate reduction in spheroid growth, highlighting the impact of drug delivery dynamics and microenviron-mental complexity on therapeutic efficacy [134].”
In vitro Approaches to Model Breast Tumor Complexity
Rosado-Galindo, H. M., Suarez, L., & Domenech, M. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96338 · Cited by 3
Advances in Micro-Bioreactor Design for Organ Cell Studies
Mandenius, C. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-232-7 · Cited by 1
An Organotypic Mammary Duct Model Capturing Distinct Events of DCIS ProgressionPreprint
Kulwatno, J., Gong, X., DeVaux, R., Herschkowitz, J. I., & Mills, K. L. (2020) · bioRxiv · doi:10.1101/2020.08.06.240242
Understanding the impact of controlled oxygen delivery to 3D cancer cell culture
Grosh, D., Wulftange, W. J., Robey, R. W., Pohida, T. J., Morgan, N. Y., & Gottesman, M. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818128-7.00027-7
Newly emerged engineering of in vitro 3D tumor models using biomaterials for chemotherapy
Cai, B., Lv, Q., Wang, Z., & Wang, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818128-7.00022-8
Zeng, X., Ma, Q., Li, X., You, L., Li, J., Fu, X., Ren, Y., & You, F. (2022) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2022-1027
Human organs-on-a-chip for cancer modeling
Hegde, M., Girisa, S., & Harsha, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00005-x
Organs-on-a-chip in drug development
Mohandas, S., Kumaran, K., & Ramkumar, K. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00001-2
Design patterns of tumor-on-chips utilizing fluidic devices and their latest trends
Mori, N., & Kida, Y. S. (2024) · Drug Delivery System · doi:10.2745/dds.39.184
Shah, S., Osuala, K. O., Brock, E. J., Ji, K., Sloane, B. F., & Mattingly, R. R. (2025) · Cells · doi:10.3390/cells14030220
“Choi and colleagues have also illustrated a novel tumor-on-chip application [155].”
Breast-on-a-Chip Technology Application Using Acacia Gums (AGs) Secondary Metabolites Extract (SME)
Elnour, A. A. M., Nour, A. H., & Ashammakhi, N. A. (2025) · Springer eBooks · doi:10.1007/978-981-97-8518-6_10
High-Performance Nanoscale Technologies for Breast Cancer: Diagnosis and Therapy Techniques
Afshari, M., Nazari-Vanani, R., Zeinali, F., Mahmoodian, Z., zad, A. I., Mohammadpour, R., & Seyedkhani, S. A. (2026) · Springer eBooks · doi:10.1007/978-981-95-3682-5_14
Hypoxia-on-chip : from technological developments to biological applications
Bouquerel, C. (2023) · theses.fr (ABES) · doi:10.70675/d7d58b5dzd927z4235z8c54z8dbb6fd4757e · Cited by 1
Targeting the cell cycle : A novel therapeutic strategy against ATIP3- deficient breast cancer
Haykal, M. M. (2023) · theses.fr (ABES) · doi:10.70675/03dee32bz395cz469ez9a0dzf4c5f2e84330
Deciphering the metabolic bases of Drosophila intestinal tumors
Delamotte, P. (2024) · theses.fr (ABES) · doi:10.70675/c62595f4zbfe2z4ee5zba1az272c10f57e2a
Amalia, A., Ismiyati, N., Illian, D. N., Setiawati, A., & Hermawan, A. (2026) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v9i3.1782
Martello, S. E., Luna, S. N., Derr, K., Franco, G. M., Paul, M., Veigh, M. M., Bellan, L. M., & Rafat, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.03.749257 · Cited by 1
Martin, E., Bessaguet, F., & Clere, N. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108465
Integrating Technologies for Synthetic, Systems, and Spatial Approaches in Cancer Research
Haynes, K. A., Adebowale, K., Akpa, B. S., Bader, J. S., Bansal, T., Breunig, J. J., Brosh, R., Bugaj, L. J., Burslem, G. M., Chadha, A., et al. (2026) · ACS Synthetic Biology · doi:10.1021/acssynbio.6c00339
Metadata
- Authors
- Choi, Y., Hyun, E., Seo, J., Blundell, C., Kim, H. C., Lee, E., Lee, S. H., Moon, A., Moon, W. K., & Huh, D.
- Affiliations
- Department of Radiology, Seoul National University Hospital, Seoul, 110-744, Republic of Korea
- Seoul National University (KR)
- University of Pennsylvania (US)
- Duksung Women's University (KR)
- Corresponding author
- Moon, Woo Kyung
- Huh, Dongeun
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2015
- Volume
- 15
- Issue
- 16
- Pages
- 3350-3357
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- PMC
- PMC4524879
- OpenAlex
- W2132922452
- Cited by
- 222
- References
- 24
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 28 · 2023: 24 · 2022: 25 · 2021: 33 · 2020: 24 · 2019: 17 · 2018: 19 · 2017: 15 · 2016: 12 · 2015: 3
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1DP2HL127720-01)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- early breast cancer, breast cancer microenvironment, ductal carcinoma in situ, tumor microenvironment, tumor spheroids, microfluidics, co-culture, mammary fibroblasts, drug screening, paclitaxel, extracellular matrix, tumor progression
- MeSH terms
- Antineoplastic Agents, Phytogenic, Breast Neoplasms, Carcinoma, Cell Survival, Cells, Cultured, Extracellular Matrix, Female, Humans, Models, Biological, Paclitaxel, Genes, Reporter, Cell Culture Techniques, Mammary Glands, Human, Microfluidic Analytical Techniques, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.